Intravenous immunoglobulin and antiphospholipid syndrome: Comment on the article by Erkan et al [2] (multiple letters)

Arthritis and Rheumatism

Volumn 50, Issue 8, 2004, Pages 2711-

  Jean, R ^a   Bastard, E ^a   Cretel, E ^a   Lefevre P ^a   Durand, J M ^a   Erkan, Doruk ^b   Asherson, Ronald ^c   Cervera, Ricard ^d   Shoenfeld, Yehuda ^e  

^a HÔPITAL DE LA CONCEPTION   (France)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d HOSPITAL CLÍNIC   (Spain)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CORTICOSTEROID; HEPARIN; IMMUNOGLOBULIN; ORAL CONTRACEPTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIPHOSPHOLIPID SYNDROME; ANTIVIRAL ACTIVITY; ARTERY THROMBOSIS; DIFFERENTIAL DIAGNOSIS; DRUG ACTIVITY; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG INFUSION; DRUG MECHANISM; DRUG TOLERABILITY; HUMAN; IMMUNOTHERAPY; LETTER; PATIENT SELECTION; PLASMAPHERESIS; PREGNANCY COMPLICATION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VEIN THROMBOSIS;

EID: 4043060828     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20387     Document Type: Letter

References (0)